Overview

TAP Blocks vs. IV Lidocaine for Kidney Transplants

Status:
Unknown status
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study will compare continuous intravenous lidocaine against single-injection transversus abdominis plane (TAP) block as a modality for postoperative analgesia in kidney transplant surgery.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Benaroya Research Institute
Treatments:
Lidocaine